Ergoteles’s Zepp Health ZEPP Stock Holding History

Ergoteles’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,579	Closed	-$49K	–	2054
2022 Q2	$49K	Buy	+6,579	New	+$60.6K	﹤0.01%	1561

Other funds holding ZEPP

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

DCM

DGS Capital Management Jersey City, New Jersey $609M AUM 44.78% 1-Year Est. Return

Ergoteles's ZEPP Position: Q3 2022 in Review

Ergoteles sold out of Zepp Health (ZEPP) in Q3 2022, closing a stake of 6,579 shares — an estimated $49K sold.

Ergoteles first reported a position in ZEPP in Q2 2022 and held it in 1 quarter. The position peaked at $49K in Q2 2022. 33 funds tracked by Wall St. Rank hold ZEPP as of Q3 2022.

Ergoteles reported no remaining Zepp Health position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 6,579 Zepp Health shares in Q3 2022, an estimated $49K.
Ergoteles first reported a position in Zepp Health in Q2 2022 and held it in 1 quarter.
Ergoteles's Zepp Health position peaked at $49K in Q2 2022.
33 funds tracked by Wall St. Rank held Zepp Health as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.